Stock Price Forecast

May 28, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Akorn, Inc. chart...

About the Company

Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health business segments. The Prescription Pharmaceuticals segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The Consumer Health segment offers branded and private-label animal health; and over-the-counter products. The company was founded in 1971 and is headquartered in Lake Forest, IL.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

2227

CEO

Douglas S. Boothe

Exchange

NASDAQ

Website

http://www.akorn.com

$721M

Total Revenue

2K

Employees

$23M

Market Capitalization

-0.06

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AKRX News

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

6y ago, source: TheStreet.com

Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share. Fresenius announced a ...

Sandoz tries to overturn Duke's $39 million court victory

12d ago, source:

A drugmaker is trying to overturn a multimillion dollar court ruling involving Duke University and another pharmaceutical ...

Global Ophthalmic Eye Drops Industry is expected to reach a significant US$24.53 Billion by 2033, driven by a steady 4.2% CAGR. | FMI

5d ago, source: Future Market Insights

The Global Ophthalmic Eye Drops Industry is poised to emerge as a beacon of growth, casting a radiant light on the expansive ...

NJ-based retailer among 50 biggest in America for 2024

2d ago, source: WKXW

Number of United States Stores in 2021: 7,019 US Retail Sales: $11.1 Billion Headquarters: Rochester, NY Number of United States Stores: 110 ...

DaVita to acquire Fresenius Medical Care entities for $300m

12d ago, source: poandpo.com

American healthcare company DaVita is set to expand its presence in the Latin American market with a $300m deal, which involves four separate acquisitions of Fresenius Medical Care entities. The U.S.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...